MITOXANTRONE

Trials studying MITOXANTRONE

• phase3A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutationactive not recruitingn=276
• phase2A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AMLactive not recruitingn=22
• phase2A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemiasuspendedn=70
• phase2TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIrecruitingn=90
• phase2Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasmsrecruitingn=62
• phase3Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLcompletedn=106
• phase2BCL2i CLAG-M in R/R Acute Myeloid Leukemiarecruitingn=52
• phase3Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AMLnot yet recruitingn=204